-
ALK-1–Negative Anaplastic Large Cell Lymphoma Associated With Breast Implants: A New Clinical Entity
October 2011 (Vol. 11 | No. 5 | Pages 283-296)
Davide Lazzeri, Tommaso Agostini, Guido Bocci, Giordano Giannotti, Giovanni Fanelli, Antonio Giuseppe Naccarato, Romano Danesi, Marco Tuccori, Marcello Pantaloni, Carlo D'Aniello
-
Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-Month Analysis of the E-ZO-FAST Trial
February 2012 (Vol. 12 | No. 1 | Pages 40-48)
Antonio Llombart, Antonio Frassoldati, Outi Paija, Harm Peter Sleeboom, Guy Jerusalem, Jeroen Mebis, Ines Deleu, Joel Miller, Nora Schenk, Patrick Neven
-
A Phase II Study of Weekly Nanoparticle Albumin-Bound Paclitaxel With or Without Trastuzumab in Metastatic Breast Cancer
April 2011 (Vol. 11 | No. 2 | Pages 121-128)
Barry Mirtsching, Thomas Cosgriff, Graydon Harker, Mark Keaton, Tarek Chidiac, Myo Min
-
Peripheral Neuropathy with Microtubule-Targeting Agents: Occurrence and Management Approach
April 2011 (Vol. 11 | No. 2 | Pages 73-81)
Karen Carlson, Allyson J. Ocean
-
Sunitinib Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel for First-Line Treatment of Patients With Advanced Breast Cancer: A Phase III, Randomized, Open-Label Trial
April 2011 (Vol. 11 | No. 2 | Pages 82-92)
Nicholas J. Robert, Mansoor N. Saleh, Devchand Paul, Daniele Generali, Laurent Gressot, Mehmet S. Copur, Adam M. Brufsky, Susan E. Minton, Jeffrey K. Giguere, John W. Smith, Paul D. Richards, Diana Gernhardt, Xin Huang, Katherine F. Liau, Kenneth A. Kern, John Davis